3528-41-4

Usage

Pyrazole derivative

A compound based on the pyrazole ring structure This indicates that the compound is derived from the pyrazole ring, which is a five-membered heterocyclic ring with two nitrogen atoms.

Benzyl group attachment

A phenyl group attached to a methylene group (-CH2-) This describes the presence of a benzyl group in the compound, which is a phenyl group connected to a methylene group.

Potential to interact with biological systems

Ability to engage with living organisms at the molecular or cellular level This suggests that the compound may have an effect on biological processes or structures.

Studied for pharmacological properties

Investigated for its potential effects on the body or its therapeutic uses This means that researchers have been looking into how the compound might be used for medical purposes.

Benzyl and phenyl groups' contribution to potential activity

The presence of these groups may influence the compound's biological activity This implies that the benzyl and phenyl groups in the molecule could play a role in determining its potential therapeutic effects.

Targeted for drug design and development

The benzyl and phenyl groups may be used as a basis for creating new drugs This suggests that the compound's structure could serve as a starting point for designing new pharmaceuticals.

Further research for potential therapeutic applications

Ongoing studies to explore the compound's possible uses in medicine This indicates that more research is needed to fully understand the potential benefits of 1-Benzyl-3-phenyl-1H-pyrazol-5-amine in treating diseases or medical conditions.

Upstream product

• 614-16-4 Benzoylacetonitrile 
• 555-96-4 Benzylhydrazine 
• 20570-96-1 benzylhydrazine dihydrochloride 

Downstream Products

• 92172-22-0 N-(2-Benzyl-5-phenyl-2H-pyrazol-3-yl)-4-methyl-benzenesulfonamide 
• 444145-44-2 1-benzyl-4-trifluoromethyl-3,6-diphenyl-1H-pyrazolo[3,4-b]pyridine 
• 1205598-10-2 N-(2-Benzyl-5-phenyl-2H-pyrazol-3-yl)-2-[3-(2-chloro-phenyl)-ureido]-2-methyl-propionamide 
• 1603826-60-3 (Z)-1-benzyl-N-(4-chloro-5H-1,2,3-dithiazol-5-ylidene)-3-phenyl-1H-pyrazol-5-amine 
• 1603826-51-2 6-benzyl-4-phenyl-6H-pyrazolo[3,4-c]isothiazole-3-carbonitrile 
• 1603826-48-7 4-phenyl-6H-pyrazolo[3,4-c]isothiazole-3-carbonitrile 
• 1603826-66-9 3-phenyl-1H-pyrazolo[4,3-d]thiazole-5-carbonitrile 
• 1603826-65-8 1-benzyl-3-phenyl-1H-pyrazolo[3,4-d]thiazole-5-carbonitrile 
• 1603826-67-0 6-benzyl-4-phenyl-6H-pyrazolo[3,4-c]isothiazole-3-carboxamide 
• 1603826-72-7 1-benzyl-3-phenyl-1H-pyrazolo[3,4-d]thiazole-5-carboxamide 

Relevant academic research and scientific papers

PYRAZOLE COMPOUND AND MEDICINAL COMPOSITION CONTAINING THE SAME

The present invention provides a novel compound having an excellent JNK inhibitory effect. That is, it provides a compound represented by the following formula, a salt thereof or a hydrate of them. Wherein R1 designates -(CO)h-(NRa)j-(CRb=CRc)k-Ar (wherein Ra, Rb and Rc each independently designate a hydrogen atom, a halogen atom, hydroxyl group, an optionally substituted C1-6 alkyl group or the like; Cy designates a 5- or 6-membered heteroaryl; and V each independently designate the formula -L-X-Y (wherein L designates a single bond, an optionally substituted C1-6 alkylene group or the like; X designates a single bond or the formula -A- (wherein A designates NR2, O, CO, S, SO or SO2) and so on; and Y designates a hydrogen atom, a halogen atom, nitro group or the like).